Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurosurgery | 10 | 2020 | 34 | 4.500 |
Why?
|
Thrombectomy | 13 | 2021 | 58 | 2.680 |
Why?
|
Intracranial Aneurysm | 8 | 2020 | 55 | 2.040 |
Why?
|
Career Choice | 5 | 2019 | 40 | 1.950 |
Why?
|
Carotid Stenosis | 5 | 2020 | 56 | 1.710 |
Why?
|
Physicians, Women | 3 | 2018 | 16 | 1.690 |
Why?
|
Embolization, Therapeutic | 10 | 2017 | 79 | 1.580 |
Why?
|
Pseudotumor Cerebri | 7 | 2020 | 19 | 1.550 |
Why?
|
Cranial Sinuses | 7 | 2020 | 20 | 1.540 |
Why?
|
Internship and Residency | 5 | 2019 | 283 | 1.450 |
Why?
|
Stents | 13 | 2020 | 171 | 1.220 |
Why?
|
Burnout, Professional | 4 | 2020 | 44 | 1.160 |
Why?
|
Stroke | 11 | 2021 | 552 | 1.150 |
Why?
|
Humans | 72 | 2021 | 29556 | 1.080 |
Why?
|
Carotid Artery, Internal | 6 | 2018 | 29 | 0.990 |
Why?
|
Male | 49 | 2021 | 18012 | 0.910 |
Why?
|
Female | 43 | 2021 | 18379 | 0.860 |
Why?
|
Treatment Outcome | 27 | 2021 | 3128 | 0.850 |
Why?
|
Tissue Plasminogen Activator | 2 | 2021 | 40 | 0.790 |
Why?
|
Retinal Artery Occlusion | 1 | 2020 | 3 | 0.760 |
Why?
|
Vision, Ocular | 1 | 2020 | 30 | 0.750 |
Why?
|
Disease Management | 2 | 2019 | 114 | 0.750 |
Why?
|
Retrospective Studies | 19 | 2021 | 3144 | 0.730 |
Why?
|
Cervical Vertebrae | 3 | 2018 | 42 | 0.720 |
Why?
|
Catheterization | 2 | 2010 | 58 | 0.720 |
Why?
|
Physicians | 5 | 2020 | 136 | 0.720 |
Why?
|
Aneurysm, Ruptured | 4 | 2018 | 26 | 0.700 |
Why?
|
Pituitary Neoplasms | 2 | 2010 | 17 | 0.680 |
Why?
|
Spinal Cord Injuries | 3 | 2009 | 32 | 0.680 |
Why?
|
Brain Ischemia | 6 | 2021 | 136 | 0.680 |
Why?
|
Cerebral Revascularization | 2 | 2020 | 9 | 0.660 |
Why?
|
Craniotomy | 1 | 2018 | 44 | 0.650 |
Why?
|
Mandibular Condyle | 1 | 2018 | 6 | 0.640 |
Why?
|
Mental Health | 1 | 2019 | 104 | 0.630 |
Why?
|
Aged | 25 | 2021 | 9590 | 0.630 |
Why?
|
Occipital Bone | 1 | 2018 | 18 | 0.630 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2017 | 11 | 0.620 |
Why?
|
Brain Injuries | 1 | 2018 | 94 | 0.620 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 29 | 0.610 |
Why?
|
Spinal Fractures | 1 | 2018 | 42 | 0.610 |
Why?
|
Aneurysm, False | 3 | 2018 | 13 | 0.590 |
Why?
|
Carotid Artery Diseases | 3 | 2018 | 110 | 0.580 |
Why?
|
Adult | 24 | 2020 | 8528 | 0.570 |
Why?
|
Health Promotion | 1 | 2019 | 223 | 0.570 |
Why?
|
Neurons | 3 | 2009 | 395 | 0.530 |
Why?
|
Time Factors | 4 | 2020 | 2014 | 0.530 |
Why?
|
Emergency Medical Services | 1 | 2017 | 158 | 0.520 |
Why?
|
Venous Pressure | 3 | 2020 | 9 | 0.520 |
Why?
|
Cost Control | 1 | 2014 | 17 | 0.500 |
Why?
|
Cerebral Angiography | 7 | 2018 | 51 | 0.500 |
Why?
|
School Admission Criteria | 1 | 2014 | 11 | 0.490 |
Why?
|
Middle Aged | 27 | 2021 | 10936 | 0.480 |
Why?
|
Interviews as Topic | 1 | 2014 | 250 | 0.460 |
Why?
|
Carotid-Cavernous Sinus Fistula | 2 | 2010 | 2 | 0.460 |
Why?
|
Intracranial Hypotension | 2 | 2018 | 3 | 0.460 |
Why?
|
Students, Medical | 1 | 2014 | 121 | 0.440 |
Why?
|
Phlebography | 4 | 2020 | 26 | 0.420 |
Why?
|
Oculomotor Nerve | 1 | 2011 | 4 | 0.400 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2011 | 6 | 0.400 |
Why?
|
Neurosurgical Procedures | 7 | 2020 | 98 | 0.390 |
Why?
|
Central Nervous System Neoplasms | 1 | 2011 | 28 | 0.390 |
Why?
|
Blood Pressure | 3 | 2020 | 813 | 0.390 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2009 | 74 | 0.380 |
Why?
|
Polyvinyls | 4 | 2011 | 7 | 0.370 |
Why?
|
Angiography | 6 | 2018 | 75 | 0.370 |
Why?
|
Central Nervous System Cysts | 1 | 2010 | 1 | 0.370 |
Why?
|
Craniopharyngioma | 1 | 2010 | 8 | 0.370 |
Why?
|
Veins | 1 | 2010 | 29 | 0.360 |
Why?
|
Orbit | 1 | 2010 | 17 | 0.360 |
Why?
|
Ossification, Heterotopic | 1 | 2010 | 14 | 0.360 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 58 | 0.360 |
Why?
|
Blood Coagulation Disorders | 1 | 2009 | 9 | 0.350 |
Why?
|
Hemangioma | 1 | 2009 | 18 | 0.350 |
Why?
|
Thrombocytopenia | 1 | 2009 | 32 | 0.350 |
Why?
|
Scalp | 1 | 2009 | 33 | 0.340 |
Why?
|
Job Satisfaction | 2 | 2020 | 37 | 0.340 |
Why?
|
Carbon Dioxide | 2 | 2020 | 36 | 0.340 |
Why?
|
United States | 8 | 2020 | 3693 | 0.340 |
Why?
|
Coronavirus Infections | 2 | 2020 | 72 | 0.340 |
Why?
|
Ventriculoperitoneal Shunt | 2 | 2018 | 7 | 0.340 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 77 | 0.330 |
Why?
|
Manometry | 2 | 2019 | 19 | 0.330 |
Why?
|
Health Personnel | 2 | 2020 | 111 | 0.330 |
Why?
|
Femoral Artery | 2 | 2020 | 44 | 0.330 |
Why?
|
Cerebral Hemorrhage | 2 | 2019 | 62 | 0.330 |
Why?
|
Cerebral Veins | 1 | 2008 | 11 | 0.320 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2008 | 18 | 0.320 |
Why?
|
Neuralgia | 1 | 2009 | 48 | 0.320 |
Why?
|
Arteriovenous Fistula | 1 | 2008 | 14 | 0.320 |
Why?
|
Intracranial Embolism | 1 | 2008 | 13 | 0.310 |
Why?
|
Angiography, Digital Subtraction | 3 | 2020 | 18 | 0.300 |
Why?
|
Prospective Studies | 11 | 2021 | 2046 | 0.300 |
Why?
|
Skin Neoplasms | 1 | 2009 | 207 | 0.290 |
Why?
|
Epidural Space | 1 | 2007 | 7 | 0.290 |
Why?
|
Brain Tissue Transplantation | 1 | 2007 | 3 | 0.290 |
Why?
|
Pain, Intractable | 1 | 2007 | 2 | 0.290 |
Why?
|
Spinal Cord Compression | 1 | 2007 | 8 | 0.290 |
Why?
|
Hyperemia | 1 | 2007 | 10 | 0.290 |
Why?
|
Glioma | 1 | 2008 | 133 | 0.290 |
Why?
|
Retinoblastoma | 3 | 2011 | 10 | 0.280 |
Why?
|
Retinal Neoplasms | 3 | 2011 | 9 | 0.280 |
Why?
|
Dimethyl Sulfoxide | 3 | 2010 | 12 | 0.270 |
Why?
|
Fibroma, Desmoplastic | 1 | 2005 | 1 | 0.270 |
Why?
|
Skull Neoplasms | 1 | 2005 | 4 | 0.270 |
Why?
|
Magnetic Resonance Angiography | 3 | 2011 | 64 | 0.260 |
Why?
|
Intracranial Pressure | 3 | 2019 | 19 | 0.250 |
Why?
|
Wounds, Nonpenetrating | 2 | 2017 | 90 | 0.240 |
Why?
|
Recovery of Function | 2 | 2020 | 190 | 0.240 |
Why?
|
Follow-Up Studies | 5 | 2020 | 2124 | 0.230 |
Why?
|
Aged, 80 and over | 9 | 2021 | 3764 | 0.230 |
Why?
|
Vascular Surgical Procedures | 2 | 2017 | 91 | 0.230 |
Why?
|
Reoperation | 2 | 2017 | 204 | 0.230 |
Why?
|
Reperfusion | 2 | 2020 | 17 | 0.230 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2021 | 85 | 0.220 |
Why?
|
Pilot Projects | 3 | 2020 | 489 | 0.210 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 494 | 0.210 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 59 | 0.210 |
Why?
|
Hospitals | 2 | 2019 | 90 | 0.210 |
Why?
|
Tantalum | 2 | 2011 | 3 | 0.190 |
Why?
|
Heparin | 1 | 2021 | 75 | 0.190 |
Why?
|
Referral and Consultation | 2 | 2019 | 113 | 0.190 |
Why?
|
Postoperative Complications | 3 | 2020 | 676 | 0.190 |
Why?
|
Independent Living | 2 | 2020 | 85 | 0.180 |
Why?
|
Retreatment | 1 | 2020 | 40 | 0.180 |
Why?
|
Radial Artery | 1 | 2020 | 15 | 0.180 |
Why?
|
Lumbar Vertebrae | 2 | 2018 | 99 | 0.180 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2020 | 32 | 0.180 |
Why?
|
Physician's Role | 1 | 2020 | 38 | 0.180 |
Why?
|
Carotid Arteries | 1 | 2020 | 97 | 0.180 |
Why?
|
Cohort Studies | 3 | 2020 | 1701 | 0.180 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2019 | 18 | 0.180 |
Why?
|
Rats, Inbred WF | 3 | 2009 | 8 | 0.180 |
Why?
|
Databases, Factual | 2 | 2018 | 333 | 0.170 |
Why?
|
Periodicals as Topic | 2 | 2019 | 95 | 0.170 |
Why?
|
Bibliometrics | 1 | 2019 | 9 | 0.170 |
Why?
|
Thrombosis | 1 | 2019 | 60 | 0.170 |
Why?
|
Decompressive Craniectomy | 1 | 2018 | 4 | 0.170 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 163 | 0.160 |
Why?
|
Healthcare Disparities | 1 | 2021 | 153 | 0.160 |
Why?
|
Infant | 4 | 2014 | 976 | 0.160 |
Why?
|
Superior Sagittal Sinus | 1 | 2018 | 6 | 0.160 |
Why?
|
Delivery of Health Care | 1 | 2020 | 145 | 0.160 |
Why?
|
Hypertension | 3 | 2020 | 918 | 0.160 |
Why?
|
Transverse Sinuses | 1 | 2018 | 5 | 0.160 |
Why?
|
Lordosis | 1 | 2018 | 2 | 0.160 |
Why?
|
Intracranial Hypertension | 1 | 2018 | 20 | 0.160 |
Why?
|
Cell Line | 3 | 2009 | 456 | 0.160 |
Why?
|
Faculty | 1 | 2018 | 15 | 0.160 |
Why?
|
Vascular Diseases | 1 | 2018 | 62 | 0.160 |
Why?
|
Certification | 1 | 2018 | 25 | 0.160 |
Why?
|
Workload | 1 | 2018 | 38 | 0.160 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 48 | 0.150 |
Why?
|
Respiration, Artificial | 1 | 2018 | 96 | 0.150 |
Why?
|
Risk Factors | 3 | 2021 | 3600 | 0.150 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 85 | 0.150 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2017 | 24 | 0.150 |
Why?
|
Feasibility Studies | 2 | 2017 | 270 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 4 | 2011 | 1225 | 0.150 |
Why?
|
Subarachnoid Space | 2 | 2007 | 5 | 0.150 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 247 | 0.150 |
Why?
|
Cooperative Behavior | 1 | 2017 | 73 | 0.140 |
Why?
|
Patient Selection | 1 | 2018 | 257 | 0.140 |
Why?
|
Child | 5 | 2014 | 2234 | 0.140 |
Why?
|
Hyperalgesia | 2 | 2007 | 88 | 0.140 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 62 | 0.140 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 209 | 0.140 |
Why?
|
Decision Support Techniques | 1 | 2017 | 104 | 0.130 |
Why?
|
Contrast Media | 1 | 2016 | 124 | 0.130 |
Why?
|
Biomedical Research | 1 | 2017 | 156 | 0.130 |
Why?
|
Personnel Selection | 1 | 2015 | 14 | 0.130 |
Why?
|
Internet | 1 | 2016 | 158 | 0.130 |
Why?
|
Rats | 3 | 2009 | 1609 | 0.130 |
Why?
|
Risk Assessment | 1 | 2020 | 1329 | 0.130 |
Why?
|
Transportation | 1 | 2014 | 14 | 0.120 |
Why?
|
Quality of Life | 1 | 2020 | 833 | 0.120 |
Why?
|
Angioplasty, Balloon | 2 | 2019 | 33 | 0.120 |
Why?
|
Constriction, Pathologic | 3 | 2018 | 44 | 0.120 |
Why?
|
Housing | 1 | 2014 | 60 | 0.120 |
Why?
|
Weight Lifting | 1 | 2013 | 9 | 0.120 |
Why?
|
Head Movements | 1 | 2013 | 13 | 0.120 |
Why?
|
Vertebral Artery | 1 | 2013 | 8 | 0.120 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2013 | 7 | 0.120 |
Why?
|
Neck Muscles | 1 | 2013 | 8 | 0.120 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 9 | 0.120 |
Why?
|
Sex Factors | 1 | 2015 | 633 | 0.110 |
Why?
|
African Americans | 1 | 2021 | 1375 | 0.110 |
Why?
|
Intraoperative Complications | 2 | 2010 | 49 | 0.110 |
Why?
|
Accidental Falls | 1 | 2014 | 211 | 0.100 |
Why?
|
Quisqualic Acid | 2 | 2009 | 2 | 0.100 |
Why?
|
Excitatory Amino Acid Agonists | 2 | 2009 | 15 | 0.100 |
Why?
|
Glycine | 2 | 2009 | 25 | 0.100 |
Why?
|
Spinal Cord Diseases | 1 | 2011 | 12 | 0.100 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2011 | 3 | 0.100 |
Why?
|
Angiofibroma | 1 | 2011 | 2 | 0.100 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2011 | 5 | 0.100 |
Why?
|
Abscess | 1 | 2011 | 25 | 0.100 |
Why?
|
Wounds and Injuries | 1 | 2014 | 251 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 3 | 2013 | 875 | 0.100 |
Why?
|
Retinal Artery | 1 | 2010 | 4 | 0.090 |
Why?
|
Ophthalmic Artery | 1 | 2010 | 9 | 0.090 |
Why?
|
Ligation | 1 | 2010 | 55 | 0.090 |
Why?
|
Laser Coagulation | 1 | 2010 | 12 | 0.090 |
Why?
|
Carotid Artery, Common | 1 | 2010 | 37 | 0.090 |
Why?
|
Cavernous Sinus | 1 | 2010 | 1 | 0.090 |
Why?
|
Eyelids | 1 | 2010 | 9 | 0.090 |
Why?
|
Pituitary Gland | 1 | 2010 | 9 | 0.090 |
Why?
|
Forehead | 1 | 2010 | 10 | 0.090 |
Why?
|
Mitosis | 1 | 2010 | 23 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2010 | 13 | 0.090 |
Why?
|
Melphalan | 1 | 2010 | 4 | 0.090 |
Why?
|
Child, Preschool | 3 | 2014 | 1172 | 0.090 |
Why?
|
Vascular Neoplasms | 1 | 2010 | 14 | 0.090 |
Why?
|
Preoperative Care | 1 | 2011 | 110 | 0.090 |
Why?
|
Immunohistochemistry | 2 | 2009 | 520 | 0.090 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 40 | 0.090 |
Why?
|
Equipment Design | 1 | 2010 | 167 | 0.090 |
Why?
|
Syndrome | 1 | 2009 | 66 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 130 | 0.090 |
Why?
|
Anesthesia, General | 2 | 2020 | 29 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2021 | 190 | 0.090 |
Why?
|
Radiography | 1 | 2010 | 355 | 0.080 |
Why?
|
Registries | 2 | 2021 | 280 | 0.080 |
Why?
|
Blood Pressure Determination | 2 | 2019 | 95 | 0.080 |
Why?
|
Young Adult | 4 | 2020 | 2431 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 242 | 0.080 |
Why?
|
Publishing | 2 | 2019 | 57 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2007 | 438 | 0.080 |
Why?
|
Spinal Cord | 1 | 2009 | 139 | 0.080 |
Why?
|
Animals | 3 | 2009 | 7339 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 337 | 0.080 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2008 | 70 | 0.080 |
Why?
|
Prevalence | 2 | 2020 | 910 | 0.070 |
Why?
|
Hydrocephalus | 1 | 2007 | 13 | 0.070 |
Why?
|
Pia Mater | 1 | 2007 | 1 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 401 | 0.070 |
Why?
|
Behavior, Animal | 1 | 2009 | 264 | 0.070 |
Why?
|
Calcinosis | 1 | 2008 | 143 | 0.070 |
Why?
|
Cell Count | 1 | 2007 | 51 | 0.070 |
Why?
|
Cell Transplantation | 1 | 2007 | 63 | 0.070 |
Why?
|
Adolescent | 3 | 2011 | 3284 | 0.070 |
Why?
|
Microsurgery | 1 | 2006 | 19 | 0.070 |
Why?
|
Graft Survival | 1 | 2007 | 228 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 1372 | 0.060 |
Why?
|
Internationality | 1 | 2021 | 21 | 0.050 |
Why?
|
Workflow | 1 | 2020 | 20 | 0.050 |
Why?
|
Catheterization, Peripheral | 1 | 2020 | 25 | 0.050 |
Why?
|
Goals | 1 | 2020 | 36 | 0.040 |
Why?
|
Journal Impact Factor | 1 | 2019 | 9 | 0.040 |
Why?
|
Linear Models | 1 | 2020 | 427 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 23 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2019 | 26 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 525 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 70 | 0.040 |
Why?
|
Paranasal Sinuses | 1 | 2018 | 6 | 0.040 |
Why?
|
Blister | 1 | 2018 | 7 | 0.040 |
Why?
|
Consensus | 1 | 2018 | 70 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2018 | 63 | 0.040 |
Why?
|
Headache | 1 | 2018 | 74 | 0.040 |
Why?
|
Hospitalization | 1 | 2021 | 423 | 0.040 |
Why?
|
Canada | 1 | 2017 | 50 | 0.040 |
Why?
|
International Cooperation | 1 | 2017 | 25 | 0.040 |
Why?
|
China | 1 | 2017 | 44 | 0.040 |
Why?
|
Patient Admission | 1 | 2017 | 53 | 0.040 |
Why?
|
Hip Joint | 1 | 2016 | 57 | 0.030 |
Why?
|
Patient Discharge | 1 | 2017 | 171 | 0.030 |
Why?
|
Risk | 1 | 2016 | 293 | 0.030 |
Why?
|
Knee Joint | 1 | 2016 | 129 | 0.030 |
Why?
|
Orthopedic Procedures | 1 | 2016 | 93 | 0.030 |
Why?
|
Length of Stay | 1 | 2016 | 296 | 0.030 |
Why?
|
Logistic Models | 1 | 2017 | 729 | 0.030 |
Why?
|
Hawaii | 1 | 2014 | 3 | 0.030 |
Why?
|
Accidents, Aviation | 1 | 2013 | 1 | 0.030 |
Why?
|
Aircraft | 1 | 2013 | 3 | 0.030 |
Why?
|
Hypertrophy | 1 | 2013 | 26 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2013 | 82 | 0.030 |
Why?
|
Rotation | 1 | 2013 | 46 | 0.030 |
Why?
|
Age Factors | 1 | 2017 | 1120 | 0.030 |
Why?
|
Gram-Positive Cocci | 1 | 2011 | 4 | 0.030 |
Why?
|
Paresis | 1 | 2011 | 10 | 0.030 |
Why?
|
Laminectomy | 1 | 2011 | 16 | 0.020 |
Why?
|
Nasopharynx | 1 | 2011 | 6 | 0.020 |
Why?
|
Necrosis | 1 | 2011 | 53 | 0.020 |
Why?
|
Spine | 1 | 2011 | 38 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 796 | 0.020 |
Why?
|
Drug Combinations | 1 | 2011 | 86 | 0.020 |
Why?
|
Endoscopy | 1 | 2011 | 40 | 0.020 |
Why?
|
Postoperative Care | 1 | 2011 | 73 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2010 | 6 | 0.020 |
Why?
|
Sclerosis | 1 | 2010 | 10 | 0.020 |
Why?
|
Etoposide | 1 | 2010 | 30 | 0.020 |
Why?
|
Vincristine | 1 | 2010 | 15 | 0.020 |
Why?
|
Cyclosporine | 1 | 2010 | 34 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2010 | 16 | 0.020 |
Why?
|
Carboplatin | 1 | 2010 | 40 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2010 | 6 | 0.020 |
Why?
|
Remission Induction | 1 | 2010 | 78 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2010 | 45 | 0.020 |
Why?
|
Visual Acuity | 1 | 2010 | 69 | 0.020 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2010 | 146 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2010 | 441 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2007 | 6 | 0.020 |
Why?
|
Antimetabolites | 1 | 2007 | 10 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2007 | 93 | 0.020 |
Why?
|
Hot Temperature | 1 | 2007 | 74 | 0.020 |
Why?
|
Pain Measurement | 1 | 2007 | 365 | 0.020 |
Why?
|
Phenotype | 1 | 2007 | 633 | 0.020 |
Why?
|
Pain | 1 | 2007 | 285 | 0.010 |
Why?
|